Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 3
1985 1
1986 5
1987 3
1988 5
1989 6
1990 1
1991 10
1992 5
1993 8
1994 5
1995 3
1996 3
1997 3
1998 8
1999 9
2000 13
2001 10
2002 6
2003 5
2004 10
2005 7
2006 11
2007 7
2008 5
2009 4
2012 1
2014 2
2015 1
2016 1
2018 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

156 results

Results by year

Filters applied: . Clear all
Page 1
Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours.
Sternberg CN, de Mulder P, Schornagel JH, Theodore C, Fossa SD, van Oosterom AT, Witjes JA, Spina M, van Groeningen CJ, Duclos B, Roberts JT, de Balincourt C, Collette L; EORTC Genito-Urinary Cancer Group. Sternberg CN, et al. Among authors: van groeningen cj. Eur J Cancer. 2006 Jan;42(1):50-4. doi: 10.1016/j.ejca.2005.08.032. Epub 2005 Dec 5. Eur J Cancer. 2006. PMID: 16330205 Clinical Trial.
Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924.
Sternberg CN, de Mulder PH, Schornagel JH, Théodore C, Fossa SD, van Oosterom AT, Witjes F, Spina M, van Groeningen CJ, de Balincourt C, Collette L; European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. Sternberg CN, et al. Among authors: van groeningen cj. J Clin Oncol. 2001 May 15;19(10):2638-46. doi: 10.1200/JCO.2001.19.10.2638. J Clin Oncol. 2001. PMID: 11352955 Clinical Trial.
A pubic mass.
Möhlmann MC, Rustemeijer C, van Groeningen CJ, Stigter DA. Möhlmann MC, et al. Among authors: van groeningen cj. Neth J Med. 2012 Oct;70(8):374-8. Neth J Med. 2012. PMID: 23065986 Free article. No abstract available.
Thymidylate synthase and drug resistance.
Peters GJ, van der Wilt CL, van Triest B, Codacci-Pisanelli G, Johnston PG, van Groeningen CJ, Pinedo HM. Peters GJ, et al. Among authors: van groeningen cj. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1299-305. doi: 10.1016/0959-8049(95)00172-f. Eur J Cancer. 1995. PMID: 7577040 Free article. Review.
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism.
Peters GJ, Backus HH, Freemantle S, van Triest B, Codacci-Pisanelli G, van der Wilt CL, Smid K, Lunec J, Calvert AH, Marsh S, McLeod HL, Bloemena E, Meijer S, Jansen G, van Groeningen CJ, Pinedo HM. Peters GJ, et al. Among authors: van groeningen cj. Biochim Biophys Acta. 2002 Jul 18;1587(2-3):194-205. doi: 10.1016/s0925-4439(02)00082-0. Biochim Biophys Acta. 2002. PMID: 12084461 Free article. Review.
Palliative chemotherapy in advanced gastrointestinal cancer.
van Riel JM, van Groeningen CJ. van Riel JM, et al. Among authors: van groeningen cj. Eur J Gastroenterol Hepatol. 2000 Apr;12(4):391-6. doi: 10.1097/00042737-200012040-00004. Eur J Gastroenterol Hepatol. 2000. PMID: 10783990 Review.
156 results